These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analogues of atriopeptin(103-125)amide having high binding selectivity. Spear KL; Brown MS; Olins GM; Patton DR J Med Chem; 1989 May; 32(5):1094-8. PubMed ID: 2540333 [TBL] [Abstract][Full Text] [Related]
3. Identification of structural requirements for analogues of atrial natriuretic peptide (ANP) to discriminate between ANP receptor subtypes. Bovy PR; O'Neal JM; Olins GM; Patton DR J Med Chem; 1989 Apr; 32(4):869-74. PubMed ID: 2564895 [TBL] [Abstract][Full Text] [Related]
4. Restriction of a peptide turn conformation and conformational analysis of guanidino group using arginine-proline fused amino acids: application to mini atrial natriuretic peptide on binding to the receptor. Sugase K; Horikawa M; Sugiyama M; Ishiguro M J Med Chem; 2004 Jan; 47(2):489-92. PubMed ID: 14711318 [TBL] [Abstract][Full Text] [Related]
5. Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation. von Geldern TW; Rockway TW; Davidsen SK; Budzik GP; Bush EN; Chu-Moyer MY; Devine EM; Holleman WH; Johnson MC; Lucas SD J Med Chem; 1992 Mar; 35(5):808-16. PubMed ID: 1347790 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of a linear fragment of the atrial natriuretic factor (ANF). Schiller PW; Maziak L; Nguyen TM; Godin J; Garcia R; De Léan A; Cantin M Biochem Biophys Res Commun; 1985 Sep; 131(3):1056-62. PubMed ID: 2996534 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of atrial natriuretic factor analogues: effect of modifications to the disulfide bridge. DiMaio J; Jaramillo J; Wernic D; Grenier L; Welchner E; Adams J J Med Chem; 1990 Feb; 33(2):661-7. PubMed ID: 2153824 [TBL] [Abstract][Full Text] [Related]
9. Disulfide and amide-bridged cyclic peptide analogues of the VEGF₈₁₋₉₁ fragment: synthesis, conformational analysis and biological evaluation. García-Aranda MI; Mirassou Y; Gautier B; Martín-Martínez M; Inguimbert N; Vidal M; García-López MT; Jiménez MA; González-Muñiz R; Pérez de Vega MJ Bioorg Med Chem; 2011 Dec; 19(24):7526-33. PubMed ID: 22078412 [TBL] [Abstract][Full Text] [Related]
10. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype. Mimeault M; Fournier A; Féthiere J; De Léan A Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232 [TBL] [Abstract][Full Text] [Related]
11. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549 [TBL] [Abstract][Full Text] [Related]
12. Specific receptors for atriopeptin III in rabbit lung. Olins GM; Patton DR; Tjoeng FS; Blehm DJ Biochem Biophys Res Commun; 1986 Oct; 140(1):302-7. PubMed ID: 3022717 [TBL] [Abstract][Full Text] [Related]
13. Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells. Leitman DC; Murad F Biochim Biophys Acta; 1986 Jan; 885(1):74-9. PubMed ID: 2867788 [TBL] [Abstract][Full Text] [Related]
14. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies. Bisello A; Nakamoto C; Rosenblatt M; Chorev M Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007 [TBL] [Abstract][Full Text] [Related]
15. Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Cahill PA; Hassid A Biochem Biophys Res Commun; 1991 Sep; 179(3):1606-13. PubMed ID: 1656960 [TBL] [Abstract][Full Text] [Related]
16. Determination of the solution structure of the peptide hormone guanylin: observation of a novel form of topological stereoisomerism. Skelton NJ; Garcia KC; Goeddel DV; Quan C; Burnier JP Biochemistry; 1994 Nov; 33(46):13581-92. PubMed ID: 7947768 [TBL] [Abstract][Full Text] [Related]
17. A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation. von Geldern TW; Budzik GP; Dillon TP Biochem Biophys Res Commun; 1992 Jun; 185(2):734-9. PubMed ID: 1319147 [TBL] [Abstract][Full Text] [Related]
19. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. Schiller PW; Nguyen TM; Lemieux C; Maziak LA J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]